查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1808876

癌症成像系统市场，按成像方式、按应用、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Cancer Imaging System Market, By Imaging Modality, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年癌症影像系统市场规模价值 219.8724 亿美元，2025 年至 2032 年的复合年增长率为 9.5%。

癌症影像系统市场是指专注于透过医学影像检测、诊断和监测癌症的技术和设备的全球产业。这些系统包括MRI（磁振造影）、CT（电脑断层扫描）、PET（正子断层扫描）、超音波和乳房X光检查等。癌症影像在早期发现、分期、治疗计划和疗效评估中发挥着至关重要的作用。全球癌症盛行率的上升、人们对早期诊断认识的提高以及成像技术的进步是该市场发展的关键驱动因素。

人工智慧增强影像解读、混合成像系统和分子成像等创新技术正在提高诊断准确性和能力。世界各地的政府和卫生组织正在投资癌症筛检项目，进一步刺激了需求。此外，日益增长的老龄化人口和与生活方式相关的癌症风险也促进了市场扩张。然而，高昂的设备成本和低收入地区的医疗资源匮乏仍然是个挑战。总体而言，市场正在快速发展，以支持精准肿瘤学和以患者为中心的医疗服务。

癌症影像系统市场-市场动态

放射组学透过提取数据驱动的肿瘤见解来实现个人化癌症成像。

癌症影像系统市场的一个利基驱动因素是放射组学在个人化肿瘤治疗中的应用日益广泛。放射组学利用先进的演算法从医学影像中提取大量定量资料。这些资料点可以揭示肉眼无法观察到的肿瘤特征，例如形状、纹理和强度。这些资讯有助于评估肿瘤异质性、预测治疗反应并提高预后准确性。随着精准医疗的进展，放射组学对于根据患者个别情况制定个人化癌症治疗方案至关重要。

它提供了一种非侵入性的方式来收集肿瘤生物学信息，从而减少了重复活检的需要。与人工智慧的结合增强了其检测模式和相关性的能力。放射组学也支持临床决策，并加速癌症治疗的研究。其在CT、MRI和PET等影像模式下的应用正在不断扩展。人们对数据驱动型医疗保健的日益关注进一步增强了其作用。随着应用的不断增长，放射组学必将对癌症成像策略产生重大影响。

癌症影像系统市场-关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 9.5%。

根据成像模式细分，预计磁振造影 (MRI) 将在 2024 年占据最大市场份额

根据应用细分，乳癌是 2024 年的主要应用

从地区来看，北美是 2024 年最大的收入来源

癌症影像系统市场-細項分析：

全球癌症成像系统市场根据成像方式、应用、最终用户和地区进行细分。

根据影像方式，市场分为三类：磁振造影 (MRI)、电脑断层扫描 (CT)、正子断层扫描 (PET)、超音波、乳房 X 光摄影和其他。磁振造影 (MRI) 是癌症成像系统市场中最主要的细分领域，因为它具有卓越的软组织对比度，并且能够在没有电离辐射的情况下提供清晰的图像。 MRI 广泛用于检测和分期各种癌症，包括脑癌、乳癌、摄护腺癌和肝癌。

其先进的功能性成像技术，例如扩散加权成像和光谱技术，能够更好地表征肿瘤并监测治疗效果。随着对非侵入式精准诊断工具的需求不断增长，以及技术的持续进步，进一步巩固了MRI在该市场的领先地位。

根据应用，市场分为两类：乳癌、肺癌、大肠癌、摄护腺癌、肝癌和其他。乳癌是癌症影像系统市场中最主要的细分领域，因为其发生率高，且对早期检测和筛检的需求迫切。乳房X光检查和核磁振造影（MRI）广泛应用于乳癌影像，以实现精准的诊断和监测。

政府筛检计画和日益增长的乳癌意识推动了影像系统的需求成长。此外，影像技术的进步提高了对小肿瘤的检测能力，从而改善了治疗效果。对乳癌的强烈关注推动了该领域市场的显着成长。

癌症成像系统市场-地理洞察

北美在癌症成像系统市场占据主导地位，这得益于其高癌症盛行率、先进的医疗基础设施以及对医疗技术的强劲投入。美国凭藉其广泛采用的先进成像模式以及人工智慧在诊断中的应用，引领了该地区的发展。政府的支持性倡议以及对早期检测日益增长的需求进一步推动了市场的成长。加拿大也为癌症筛检计画的兴起和现代影像设备普及率的提高做出了贡献。

美国是全球最大的癌症影像系统市场，得益于其高发病率和完善的医疗保健体系。该国在诊断技术方面投入了大量资金，MRI、CT、PET 和混合成像技术广泛应用于早期癌症检测和治疗监测。诸如「癌症登月计画」和扩大医疗保险对筛检程序覆盖范围等政府倡议，提升了影像服务的可及性。

癌症影像系统市场-竞争格局：

癌症影像系统市场的竞争格局以多家全球和地区性企业为特征，这些企业提供广泛的影像解决方案。通用电气医疗、西门子医疗和飞利浦医疗等产业领导者凭藉全面的影像产品组合和强大的研发实力占据主导地位。这些公司专注于创新，整合人工智慧、放射组学和先进软体，以提高诊断精度。佳能医疗和富士胶片等中型企业则透过利基技术和策略合作伙伴关係竞争。新创公司和新兴公司正透过提供针对肿瘤学的人工智慧驱动成像解决方案而不断取得进展。

市场竞争激烈，参与者纷纷投资FDA审批、与癌症研究机构合作、全球扩张。技术进步，尤其是在混合成像和分子诊断领域的进步，正在重塑市场格局。定价策略、服务产品和安装后支援也会影响竞争定位。个人化医疗和早期癌症检测的推动力持续推动关键利害关係人之间的创新和竞争。

最新动态：

2024年12月，Guardant Health, Inc. 宣布与勃林格殷格翰建立合作伙伴关係，以获得监管部门的批准并推进Guardant360 CDx液体活检的商业化。此次合作的重点是将液体活检技术作为zongertinib的伴随诊断（CDx）。 zongertinib是一种新型共价酪胺酸激酶抑制剂（TKI），可选择性靶向HER2，同时最大程度地降低对非小细胞肺癌（NSCLC）中表皮生长因子受体（EGFR）的影响。

丹纳赫集团于2024年11月宣布，计画成立两个新的诊断创新中心，以推动精准医疗的发展。第一个中心位于英国纽卡斯尔，预计将于7月投入运营，并将成为丹纳赫与领先製药和学术合作伙伴的合作研究中心。该中心由丹纳赫旗下子公司徕卡生物系统公司经营，将成为丹纳赫首个获得CLIA CAP认证的实验室。

目录

第一章：癌症影像系统市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 癌症影像系统市场片段（以影像方式）
    • 癌症影像系统市场片段（按应用）
    • 癌症影像系统市场片段（按最终用户）
    • 癌症影像系统市场（按国家/地区）
    • 癌症影像系统市场（按地区）
  • 竞争洞察

第三章：癌症影像系统关键市场趋势

  • 癌症影像系统市场驱动因素
    • 市场驱动因素的影响分析
  • 癌症影像系统市场限制因素
    • 市场限制的影响分析
  • 癌症影像系统市场机会
  • 癌症影像系统市场未来趋势

第四章：癌症影像系统产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：癌症影像系统市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：癌症影像系统市场格局

  • 2024年癌症影像系统市占分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：癌症影像系统市场－依影像方式

  • 概述
    • 按成像方式分類的细分市场占有率分析
    • 磁振造影（MRI）
    • 电脑断层扫描（CT）
    • 正子断层扫描（PET）
    • 超音波
    • 乳房X光检查
    • 其他的

第 8 章：癌症影像系统市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 乳癌
    • 肺癌
    • 大肠直肠癌
    • 摄护腺癌
    • 肝癌
    • 其他的

第九章：癌症影像系统市场－按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 诊断影像中心
    • 专科诊所
    • 学术和研究机构

第 10 章：癌症影像系统市场-按地域划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美癌症成像系统主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（依影像方式）
    • 北美市场规模和预测（按应用）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲癌症成像系统主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（依影像方式）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区癌症影像系统主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依影像方式）
    • 亚太地区市场规模及预测（按应用）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲癌症成像系统主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（以成像方式）
    • 拉丁美洲市场规模及预测（按应用）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲癌症影像系统主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依影像方式）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：关键供应商分析-癌症影像系统产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • GE HealthCare
    • Siemens Healthineers
    • Philips Healthcare
    • Canon Medical Systems
    • Fujifilm Holdings
    • Hologic Inc.
    • Bracco Imaging
    • Carestream Health
    • Esaote SpA
    • Shimadzu Corporation
    • Samsung Medison
    • United Imaging Healthcare
    • PerkinElmer Inc.
    • Agfa-Gevaert Group
    • Konica Minolta Healthcare
    • Mindray Medical International
    • Neusoft Medical Systems
    • ViewRay Inc.
    • Hyperfine Inc.
    • Median Technologies

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5509

Cancer Imaging System Market size was valued at US$ 21,987.24 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

The Cancer Imaging System market refers to the global industry focused on technologies and equipment used to detect, diagnose, and monitor cancer through medical imaging. These systems include modalities such as MRI (Magnetic Resonance Imaging), CT (Computed Tomography), PET (Positron Emission Tomography), ultrasound, and mammography. Cancer imaging plays a vital role in early detection, staging, treatment planning, and evaluating the effectiveness of therapies. Increasing global cancer prevalence, rising awareness about early diagnosis, and advancements in imaging technologies are key drivers of this market.

Innovations like AI-enhanced image interpretation, hybrid imaging systems, and molecular imaging are improving accuracy and diagnostic capabilities. Governments and health organizations worldwide are investing in cancer screening programs, further fueling demand. Moreover, the growing aging population and lifestyle-related cancer risks contribute to market expansion. However, high equipment costs and limited access in low-income regions remain challenges. Overall, the market is evolving rapidly to support precision oncology and patient-centred care.

Cancer Imaging System Market- Market Dynamics

Radiomics enables personalized cancer imaging by extracting data-driven tumor insights.

A niche driver in the Cancer Imaging System market is the growing use of radiomics for personalized oncology. Radiomics involves extracting large volumes of quantitative data from medical images using advanced algorithms. These data points can reveal tumor characteristics such as shape, texture, and intensity that are not visible to the naked eye. This information helps in assessing tumor heterogeneity, predicting treatment response, and improving prognostic accuracy. As precision medicine advances, radiomics is becoming crucial for tailoring cancer treatment to individual patients.

It offers a non-invasive way to gather tumor biology insights, reducing the need for repeated biopsies. Integration with artificial intelligence enhances its ability to detect patterns and correlations. Radiomics also supports clinical decision-making and speeds up research in cancer therapeutics. Its application is expanding in imaging modalities like CT, MRI, and PET. The increasing focus on data-driven healthcare further strengthens its role. As adoption grows, radiomics is set to significantly impact cancer imaging strategies.

Cancer Imaging System Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2025-2032)

Based on Imaging Modality segmentation, Magnetic Resonance Imaging (MRI) was predicted to show maximum market share in the year 2024

Based on application segmentation, Breast Cancer was the leading application in 2024

Based on region, North America was the leading revenue generator in 2024

Cancer Imaging System Market- Segmentation Analysis:

The Global Cancer Imaging System Market is segmented on the basis of Imaging Modality, Application, End-user, and Region.

The market is divided into three categories based on Imaging Modality: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Ultrasound, Mammography, and Others. Magnetic Resonance Imaging (MRI) is the most dominant segment in the Cancer Imaging System market due to its superior soft tissue contrast and ability to provide detailed images without ionizing radiation. MRI is widely used for detecting and staging various cancers, including brain, breast, prostate, and liver cancers.

Its advanced functional imaging techniques, such as diffusion-weighted imaging and spectroscopy, enable better tumor characterization and treatment monitoring. Growing demand for non-invasive and precise diagnostic tools, along with continuous technological advancements, further strengthens MRI's leading position in this market.

The market is divided into two categories based on application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Others. Breast Cancer is the most dominant segment in the Cancer Imaging System market due to its high prevalence and the critical need for early detection and screening. Mammography and MRI are widely used for breast cancer imaging, enabling accurate diagnosis and monitoring.

Government screening programs and growing awareness about breast cancer contribute to increased demand for imaging systems. Additionally, advancements in imaging technology have improved the detection of small tumors, enhancing treatment outcomes. This strong focus on breast cancer drives significant market growth within this segment.

Cancer Imaging System Market- Geographical Insights

North America holds a dominant position in the Cancer Imaging System market, driven by high cancer prevalence, advanced healthcare infrastructure, and strong investment in medical technology. The U.S. leads the region with widespread adoption of advanced imaging modalities and integration of AI in diagnostics. Supportive government initiatives and increasing demand for early detection further boost growth. Canada also contributes to rising cancer screening programs and growing access to modern imaging equipment.

The United States represents the largest market for cancer imaging systems globally, supported by a high incidence of cancer and a well-established healthcare system. The country sees significant investments in diagnostic technologies, with widespread use of MRI, CT, PET, and hybrid imaging for early cancer detection and treatment monitoring. Government initiatives like the Cancer Moonshot and expanded Medicare coverage for screening procedures enhance accessibility to imaging services.

Cancer Imaging System Market- Competitive Landscape:

The competitive landscape of the Cancer Imaging System market is characterized by the presence of several global and regional players offering a wide range of imaging solutions. Industry leaders like GE HealthCare, Siemens Healthineers, and Philips Healthcare dominate with comprehensive imaging portfolios and strong R&D capabilities. These companies focus on innovation, integrating AI, radiomics, and advanced software to improve diagnostic precision. Mid-tier players such as Canon Medical and Fujifilm compete through niche technologies and strategic partnerships. Startups and emerging firms are gaining ground by offering AI-driven imaging solutions tailored for oncology.

The market is highly competitive, with players investing in FDA approvals, collaborations with cancer research institutions, and global expansion. Technological advancements, especially in hybrid imaging and molecular diagnostics, are reshaping market dynamics. Pricing strategies, service offerings, and post-installation support also influence competitive positioning. The push toward personalized medicine and early cancer detection continues to drive innovation and rivalry among key stakeholders.

Recent Developments:

In December 2024, Guardant Health, Inc. announced a partnership with Boehringer Ingelheim to secure regulatory approval and advance the commercialization of the Guardant360 CDx liquid biopsy. This collaboration focuses on utilizing the liquid biopsy as a companion diagnostic (CDx) for zongertinib, a novel covalent tyrosine kinase inhibitor (TKI) that selectively targets HER2 while minimizing effects on the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC).

In November 2024, Danaher Corporation revealed plans to establish two new Centers of Innovation in Diagnostics to drive advancements in precision medicine. The first center, based in Newcastle, UK, is set to open in July and will serve as a collaborative research hub with leading pharmaceutical and academic partners. Operated by Leica Biosystems, a Danaher subsidiary, this facility will become Danaher's first CLIA CAP-certified laboratory.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER IMAGING SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE HealthCare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon Medical Systems
  • Fujifilm Holdings
  • Hologic Inc.
  • Bracco Imaging
  • Carestream Health
  • Esaote SpA
  • Shimadzu Corporation
  • Samsung Medison
  • United Imaging Healthcare
  • PerkinElmer Inc.
  • Agfa-Gevaert Group
  • Konica Minolta Healthcare
  • Mindray Medical International
  • Neusoft Medical Systems
  • ViewRay Inc.
  • Hyperfine Inc.
  • Median Technologies

GLOBAL CANCER IMAGING SYSTEM MARKET, BY IMAGING MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Ultrasound
  • Mammography
  • Others

GLOBAL CANCER IMAGING SYSTEM MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Liver Cancer
  • Others

GLOBAL CANCER IMAGING SYSTEM MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Imaging Centers
  • Specialty Clinics
  • Academic and Research Institutes

GLOBAL CANCER IMAGING SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Imaging System Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Imaging System Market Snippet by Imaging Modality
    • 2.1.2. Cancer Imaging System Market Snippet by Application
    • 2.1.3. Cancer Imaging System Market Snippet by End-user
    • 2.1.4. Cancer Imaging System Market Snippet by Country
    • 2.1.5. Cancer Imaging System Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Imaging System Key Market Trends

  • 3.1. Cancer Imaging System Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Imaging System Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Imaging System Market Opportunities
  • 3.4. Cancer Imaging System Market Future Trends

4. Cancer Imaging System Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Imaging System Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cancer Imaging System Market Landscape

  • 6.1. Cancer Imaging System Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Imaging System Market - By Imaging Modality

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Imaging Modality, 2024 & 2032 (%)
    • 7.1.2. Magnetic Resonance Imaging (MRI)
    • 7.1.3. Computed Tomography (CT)
    • 7.1.4. Positron Emission Tomography (PET)
    • 7.1.5. Ultrasound
    • 7.1.6. Mammography
    • 7.1.7. Others

8. Cancer Imaging System Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Breast Cancer
    • 8.1.3. Lung Cancer
    • 8.1.4. Colorectal Cancer
    • 8.1.5. Prostate Cancer
    • 8.1.6. Liver Cancer
    • 8.1.7. Others

9. Cancer Imaging System Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Imaging Centers
    • 9.1.4. Specialty Clinics
    • 9.1.5. Academic and Research Institutes

10. Cancer Imaging System Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cancer Imaging System Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cancer Imaging System Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cancer Imaging System Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Cancer Imaging System Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Cancer Imaging System Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cancer Imaging System Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. GE HealthCare
    • 11.2.2. Siemens Healthineers
    • 11.2.3. Philips Healthcare
    • 11.2.4. Canon Medical Systems
    • 11.2.5. Fujifilm Holdings
    • 11.2.6. Hologic Inc.
    • 11.2.7. Bracco Imaging
    • 11.2.8. Carestream Health
    • 11.2.9. Esaote SpA
    • 11.2.10. Shimadzu Corporation
    • 11.2.11. Samsung Medison
    • 11.2.12. United Imaging Healthcare
    • 11.2.13. PerkinElmer Inc.
    • 11.2.14. Agfa-Gevaert Group
    • 11.2.15. Konica Minolta Healthcare
    • 11.2.16. Mindray Medical International
    • 11.2.17. Neusoft Medical Systems
    • 11.2.18. ViewRay Inc.
    • 11.2.19. Hyperfine Inc.
    • 11.2.20. Median Technologies

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us